AbbVie Looks To Ditch FCA Suit Alleging Humira Kickbacks
By Adam Lidgett ( November 1, 2018, 4:24 PM EDT) -- AbbVie Inc. has urged an Illinois federal judge to let it escape a False Claims Act suit over an alleged kickback scheme to boost prescriptions of its blockbuster immunosuppressant drug Humira through the use of a network of nurse "ambassadors."...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.